Product news

Share this article:

Sciele Pharma expaned its alliance with Sanofi-Aventis with a new exclusive, three-year agreement to market Allegra orally disintegrating tablets (ODT) and Allegra oral suspension in the pediatric market in the US. Under terms of the deal, Sciele will be responsible for all sales and marketing programs associated with the products in the US and will share revenues on both Allegra OS and ODT. Sciele expects to launch Allegra ODT in March 2008 through its 100 pediatric sales representatives.

Hisamitsu Pharmaceutical Co. obtained FDA approval for its topical analgesic product, Salonpas pain relief patch code-named FS-67.The product contains methyl salicylate and l-menthol as active ingredients and will be marketed as an OTC topical pain-reliever under the names of Salonpas  pain relief patch and Salonpas arthritis pain by Hisamitsu America.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.